Rokotehaitoista raportoidaan myös fiilispohjalta – ”Ikävä asia on itse asiassa hyvä uutinen”
Todennäköistä onkin, että ihminen itse kokee rokotteesta seuranneen reaktion vakavaksi, vaikkei se sitä virallisten kriteereiden mukaan olisikaan, kirjoittaa toimittaja Emmi Tuomisto.// 12.2.2021
Delta variant makes it even more important to get a COVID-19 vaccine, even if you've already had the coronavirus
COVID-19 vaccination produces a more consistent immune response than a past infection. With the delta variant, the difference in protection may be even greater.// 13.7.2021
COVID-19 vaccines dampen genomic diversity of SARS-CoV-2: Unvaccinated patients exhibit more antigenic mutational variance
Variants of SARS-CoV-2 are evolving under a combination of immune selective pressure in infected hosts and natural genetic drift, raising a global alarm regarding the durability of COVID-19 vaccines. // 5.7.2021
Three Studies, One Result: Vaccines Point the Way Out of the Pandemic
Three scientific studies offered fresh evidence that widely used vaccines will continue to protect people against the coronavirus for long periods, possibly for years, and can be adapted to fortify the immune system still further if needed. // 29.6.2021
Mielipide: Aspiroinnin ohittaminen on covid-19-rokotustekniikan virhe
Perusoikeuksiin kuuluu saada rokotus oikealla, turvallisella ja tehokkaalla rokotustekniikalla, jolla varmistetaan rokotekomplikaatioiden minimointi ja immuunivasteen maksimointi, kirjoittaa FT, MBA Helena Torkkeli.// 18.6.2021
COVID-19 Vaccines Work in People with Cancer: Study
Moderna's, Pfizer's, and Johnson & Johnson's shots all offered protection against the virus regardless of cancer type, although slightly less so in people with blood cancer.// 25.6.2021
Sperm Parameters Before and After COVID-19 mRNA Vaccination
To address vaccine hesitancy based on concerns about fertility, this study assesses sperm parameters before and after mRNA vaccine administration.// 17.6.2021
Nature - Analysis of antigen-specific B cells in lymph nodes of individuals vaccinated with BNT162b2 reveals lasting germinal centre responses, explaining the robust humoral immunity induced by...// 28.6.2021
How risky are side effects from COVD-19 vaccines? Not very
Allergic reactions, blood clots and possibly heart problems are rare and their risks don’t outweigh the benefits of getting vaccinated, experts say. // 1.6.2021
Find out how effective the COVID-19 vaccine is and how it protects you. Including how efficacy was measured, why you need a second dose and transmitting COVID-19.
Fact Check-There is no evidence to suggest COVID-19 vaccines will kill people by causing antibody- dependent enhancement, current evidence demonstrates the opposite
A baseless quote has been widely attributed to a Nobel Prize winner to claim people will die from antibody-dependent enhancement after receiving a COVID-19 jab. There is no evidence to back up this claim, nor was Reuters able to find any instance where the laureate made...// 26.5.2021
Extended interval BNT162b2 vaccination enhances peak antibody generation in older people
Objectives To assess the relative immunogenicity of standard or extended interval BNT162b2 vaccination. Design Population based cohort study comparing immune responses 2 weeks after the second vaccine, with appropriate time-matched samples in participants who received standard or extended interval double vaccination. / 17.5.2021
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies
Many SARS-CoV-2-infected individuals remain asymptomatic. Little is known about the extent and quality of their antiviral humoral response. Here, we analyze antibody functions in 52 asymptomatic infected individuals, 119 mildly symptomatic, and 21 hospitalized ...// 18.5.2021
Voinko tartuttaa, voinko sairastua vielä koronaan, entä virusmuunnokset... Saitko koronarokotteen – tässä 8 olennaista kysymystä ja vastausta sinulle juuri nyt
THL:n ylilääkäri Hanna Nohynek vastaa rokotteita koskeviin kysymyksiin Ilta-Sanomien haastattelussa.// 11.5.2021